President Donald Trump defended his decision to waive new sanctions against Russia on Sunday, October 18. He argued that imposing additional penalties now could push Moscow away from negotiations aimed …
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …